| Literature DB >> 36040711 |
Anna Paula Marçal1, Nícia Soares1, Laila Asth1, Fabricio A Moreira1, Adaliene V M Ferreira2, Daniele C Aguiar3.
Abstract
The excessive consumption of ultra-processed foods and the development of obesity has been associated with several comorbidities, including psychiatric disorders. Excess fat tissue promotes a low-intensity inflammatory state, mainly in the white tissue, which is essential in developing metabolic alterations and influences brain homeostasis. In this scenario, Cannabidiol (CBD), a compound from Cannabis sativa, has presented anxiolytic and anti-inflammatory effects in murine models. This study verified whether CBD treatment would ameliorate the compulsive-like and anxiety-like behaviors observed after mice's chronic consumption of a high-refined carbohydrate (HC) diet. BALB/c male mice received a control or HC diet for 12 weeks followed by vehicle and CBD (30 mg/Kg, i.p.) administration, and their behavior was evaluated in the Marble Burying test (MB) and Novel Suppressing Feeding test (NSF). The sub-chronic, but not acute, treatment with CBD attenuated the compulsive-like and anxiogenic-like behavior induced by the HC diet. Our data reinforced the harmful effects of the HC diet's chronic consumption on compulsive and anxious behaviors and the potential of CBD as a drug treatment for psychiatric disorders associated with obesity.Entities:
Keywords: Anxiety; Cannabidiol; High-carbohydrate diet; Obesity; Obsessive-compulsive disorder
Year: 2022 PMID: 36040711 DOI: 10.1007/s11011-022-01071-9
Source DB: PubMed Journal: Metab Brain Dis ISSN: 0885-7490 Impact factor: 3.655